ISMRM 21st Annual Meeting & Exhibition ○ 20-26 April 2013 ○ Salt Lake City, Utah, USA
SUNRISE EDUCATIONAL COURSE
Hot Topics in Body MRI
SKILL LEVEL: Intermediate to Advanced
ORGANIZERS: Masoom A. Haider, M.D., F.R.C.P.C., Shahid M. Hussain, M.D., Ph.D., John P. Mugler, III, Ph.D., Caroline Reinhold, M.D. & Shreyas S. Vasanawala, M.D., Ph.D.
TARGET AUDIENCE
This course is aimed at radiologists who wish to introduce new disease classifications, management strategies and techniques into their body MR practice. The course content will also be of interest to MR technologists and clinical support scientists involved in body MRI.
Tuesday, 23 April 2013
OVERVIEW
Contrast-enhanced MR angiography (CE-MRA) allows assessment of vascular disorders non-invasively. With normal renal function, gadolinium-based contrast agents (GBCAs) are considered safe and can provide superb imaging of the arteries as well as the veins. Safety concerns in regard to the use of GBCAs in patients with renal dysfunction have once again focused attention on non-contrast MRA. This course will focus both on CE-MRA and non-contrast MRA to allow the attendees to become familiar with both methods to improve their clinical practice.
EDUCATIONAL OBJECTIVES Upon completion of this course, participants should be able to:
Implement non-contrast and contrast-enhanced MRA sequences, and contrast-enhanced MRV in their daily clinical practice; and Recognize the indications, pitfalls and accuracy of non-contrast and contrast-enhanced MRA.
Body Vascular Imaging
Moderator: Shahid M. Hussain, M.D., Ph.D.
07:00 |  |  | Non-Contrast MRA | Mitsue Miyazaki, Ph.D.
07:25 |  |  | Contrast-Enhanced MRA & MRV | Pejman Ghanouni, M.D., Ph.D.
07:50 |  |  | Adjournment |
Wednesday, 24 April 2013
OVERVIEW
This one-hour course focuses on the correlation between the genotype and phenotype of various subtypes of liver cell adenoma and renal cell carcinoma, using a multiparametric approach. State-of-the-art techniques for evaluating the various subtypes of liver cell adenoma and renal cell carcinoma will be described. In addition, the clinical relevance of the different MR phenotypes will be highlighted. All lectures feature didactic-interactive lectures using audience response technology.
EDUCATIONAL OBJECTIVES Upon completion of this course, participants should be able to:
Diagnose the various histological subtypes of liver cell adenoma based on their MR imaging characteristics, and understand the association between genotype and phenotype; and Diagnose the various histological subtypes of renal masses based on a multi-parametric approach.
Genotype to Phenotype
Moderators: Raj Mohan Paspulati, M.D. & Caroline Reinhold, M.D.
07:00 |  |  | Liver Cell Adenoma: A New Perspective | Raj Mohan Paspulati, M.D.
07:25 |  |  | The MRI Phenotype in Renal Cell Carcinoma: Is It Clinically Relevant? | Ivan Pedrosa, M.D.
07:50 |  |  | Adjournment |
Thursday, 25 April 2013
OVERVIEW
This one-hour course will review the MRI findings in cholangiocarcinoma and their surgical classification and management. The MRI findings and imaging techniques for cystic pancreatic lesions will be described, including an algorithmic approach to management of these lesions based on imaging findings and clinical context.
EDUCATIONAL OBJECTIVES Upon completion of this course, participants should be able to:
Diagnose and assess tumour spread in patients with suspected cholangiocarcinoma, and predict surgical respectability; and Characterize cystic lesions of the pancreas and construct an algorithm for the management of these patients.
Biliary Tree & Pancreas
Moderator: Masoom A. Haider, M.D., F.R.C.P.C.
07:00 |  |  | Cholangiocarcinoma: Case Studies | Karik S. Jhaveri, M.D.
07:25 |  |  | MR Imaging and Management of Cystic Pancreatic Lesions | Koenraad J. Mortele, M.D.
07:50 |  |  | Adjournment |